Warby Parker Inc. WRBY
NYSE · XNYS · stock · Ophthalmic Goods
Chart by TradingView
5/9
Piotroski F — financial health
-0.22
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $871.9M | $1.6M | $470.6M | $43.7M | $367.7M |
| 2024 | $771.3M | -$20.4M | $426.8M | $34.7M | $340.1M |
| 2023 | $669.8M | -$63.2M | $365.2M | $7.3M | $301.8M |
| 2022 | $598.1M | -$110.4M | $341.1M | -$49.8M | $286.6M |
| 2021 | $540.8M | -$144.3M | $317.7M | -$80.5M | $286.0M |
| 2020 | $393.7M | -$55.9M | $231.9M | $12.7M | -$198.1M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Briggs Teresa | director | 2026-06-16 | Sell | 3,092 | $25.41 |
| Briggs Teresa | director | 2026-06-16 | Sell | 1,908 | $26.79 |
| Moon Youngme E | director | 2026-06-12 | Sell | 10,000 | $26.53 |
| WILLIAMS RONALD A | director | 2026-06-08 | Grant | 13,006 | — |
| SINGER BRADLEY E | director | 2026-06-08 | Grant | 9,004 | — |
| Raider Jeffrey Jacob | director | 2026-06-08 | Grant | 9,004 | — |
| Hunt Andrew | director | 2026-06-08 | Grant | 12,005 | — |
| Moon Youngme E | director | 2026-06-08 | Grant | 9,004 | — |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.22 (distress)
- Working capital / assets 0.281
- Retained earnings / assets -0.951
- EBIT / assets -0.007
- Equity / liabilities 1.041
Source: SEC EDGAR filings · CIK 0001504776 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.